SCHEMBL28638616

SCHEMBL28638616

O=C(CN1CCc2cc(Br)ccc21)N1CCCCC1.O=C(Cn1ccc2cc(Br)ccc21)N1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 7/20 0.50
▸ CHRM3 P20309 6/20 0.50
▸ CHRM4 P08173 5/20 0.50
▸ CHRM1 P11229 4/20 0.50
▸ IDO1 P14902 1/20 0.43
▸ KRAS P01116 4/20 0.41
▸ HTR7 P34969 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ NTSR1 P30989 1/20 0.39
▸ F10 P00742 1/20 0.39
▸ GRIN2B Q13224 1/20 0.38
▸ SCN7A Q01118 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29930198 0.87 IDO1 (0.53) IDO1KRASHTR7NTSR1GRIN2B
SCHEMBL29930872 0.87 CHRM2 (0.63) CHRM2CHRM3CHRM4CHRM1IDO1
SCHEMBL20604745 0.76 KMT2A (0.56) KRASNTSR1GRIN2B
SCHEMBL28928351 0.72 CHRM2 (0.75) CHRM2CHRM3CHRM4CHRM1GRIN2B
SCHEMBL20786909 0.71 KDM4E (0.50) IDO1F10NPC1HPGDSMN1; SMN2
SCHEMBL6840419 0.70 F2 (0.54) GRIN2B
SCHEMBL20676201 0.70 KRAS (0.47) CHRM2CHRM3CHRM4CHRM1IDO1
SCHEMBL29930736 0.69 CHRM2 (0.80) CHRM2CHRM3CHRM4CHRM1HPGD
SCHEMBL418013 0.68 KMT2A (0.60) KRASHTR7NTSR1
SCHEMBL2008953 0.67 HTR2A (0.55) KRASHTR7NTSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113527172-B M2 acetylcholine receptor antagonists and uses thereof 上海交通大学医学院附属仁济医院 2022-10-25 — — CN disclosed
CN-113527172-A M2 acetylcholine receptor antagonists and uses thereof 上海交通大学医学院附属仁济医院 2021-10-22 — — CN disclosed
Send feedback